Class IIIOngoing

Doxazosin Tablets recall

FDA recall D-0306-2026 · initiated Jan 21, 2026

Unlikely to cause harm but violates FDA labeling or manufacturing regulations.

Why it was recalled

Tablets/Capsules Imprinted with Wrong ID

Details

Product: Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
Recalling company: Unichem Labs Ltd
Classification: Class III
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: Nationwide
Initiated: Jan 21, 2026
FDA report date: Feb 18, 2026

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0306-2026 ↗

← All drug recalls